Clinical data show that the overall expression levels of PD-1 and PD-L1 are reduced in patients with coronary artery disease (CAD) and acute coronary syndrome, further confirming the protective role of the PD-1 pathway in the development and progression of atherosclerosis (37). This evidence concerns the gene PDCD1 and coronary artery disorder.